Adial Pharmaceuticals, Inc. (ADIL)
2.56
-0.13
(-4.83%)
USD |
NASDAQ |
Feb 19, 16:00
2.56
0.00 (0.00%)
Pre-Market: 08:56
Adial Pharmaceuticals EPS Diluted (Quarterly) : -2.022 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | -1.226 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.794M |
| Total Expenses (Quarterly) | 1.794M |
| Enterprise Value | -1.762M |
| Earnings Yield | -584.7% |
| Normalized Earnings Yield | -584.71 |